Pharmaceutical Regulatory Affairs Journals Publications

High Impact List of Articles

• Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe

  Review: Clinical Trail Outcomes: Clinical Investigation

• Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe

  Review: Clinical Trail Outcomes: Clinical Investigation

• Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe

  Review: Clinical Trail Outcomes: Clinical Investigation

• Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe

  Review: Clinical Trail Outcomes: Clinical Investigation

• Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe

  Review: Clinical Trail Outcomes: Clinical Investigation

• Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe

  Review: Clinical Trail Outcomes: Clinical Investigation

• Potential benefits of ketamine seen in antidepressent clinical trial

  News and Views: Clinical Investigation

• Potential benefits of ketamine seen in antidepressent clinical trial

  News and Views: Clinical Investigation

• Potential benefits of ketamine seen in antidepressent clinical trial

  News and Views: Clinical Investigation

• Potential benefits of ketamine seen in antidepressent clinical trial

  News and Views: Clinical Investigation

• Potential benefits of ketamine seen in antidepressent clinical trial

  News and Views: Clinical Investigation

• Potential benefits of ketamine seen in antidepressent clinical trial

  News and Views: Clinical Investigation

• Developing clinical research infrastructure in Scotland: the Scottish Dementia Clinical Research Network Peter J Connelly, Emma Law, John M Starr

  Research Update: Clinical Investigation

• Developing clinical research infrastructure in Scotland: the Scottish Dementia Clinical Research Network Peter J Connelly, Emma Law, John M Starr

  Research Update: Clinical Investigation

• Developing clinical research infrastructure in Scotland: the Scottish Dementia Clinical Research Network Peter J Connelly, Emma Law, John M Starr

  Research Update: Clinical Investigation

• Developing clinical research infrastructure in Scotland: the Scottish Dementia Clinical Research Network Peter J Connelly, Emma Law, John M Starr

  Research Update: Clinical Investigation

• Developing clinical research infrastructure in Scotland: the Scottish Dementia Clinical Research Network Peter J Connelly, Emma Law, John M Starr

  Research Update: Clinical Investigation

• Developing clinical research infrastructure in Scotland: the Scottish Dementia Clinical Research Network Peter J Connelly, Emma Law, John M Starr

  Research Update: Clinical Investigation

• New developments in the treatment of chronic thromboembolic pulmonary hypertension*** Pharmacological treatment of CTEPH Irene M Lang

  Review: Clinical Trail Outcomes: Clinical Investigation

• New developments in the treatment of chronic thromboembolic pulmonary hypertension*** Pharmacological treatment of CTEPH Irene M Lang

  Review: Clinical Trail Outcomes: Clinical Investigation

• New developments in the treatment of chronic thromboembolic pulmonary hypertension*** Pharmacological treatment of CTEPH Irene M Lang

  Review: Clinical Trail Outcomes: Clinical Investigation

• New developments in the treatment of chronic thromboembolic pulmonary hypertension*** Pharmacological treatment of CTEPH Irene M Lang

  Review: Clinical Trail Outcomes: Clinical Investigation

• New developments in the treatment of chronic thromboembolic pulmonary hypertension*** Pharmacological treatment of CTEPH Irene M Lang

  Review: Clinical Trail Outcomes: Clinical Investigation

• New developments in the treatment of chronic thromboembolic pulmonary hypertension*** Pharmacological treatment of CTEPH Irene M Lang

  Review: Clinical Trail Outcomes: Clinical Investigation

• Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications Dilip Nazareth, Peter Davies

  Editorial: Clinical Investigation

• Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications Dilip Nazareth, Peter Davies

  Editorial: Clinical Investigation

• Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications Dilip Nazareth, Peter Davies

  Editorial: Clinical Investigation

• Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications Dilip Nazareth, Peter Davies

  Editorial: Clinical Investigation

• Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications Dilip Nazareth, Peter Davies

  Editorial: Clinical Investigation

• Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications Dilip Nazareth, Peter Davies

  Editorial: Clinical Investigation

Relevant Topics in Clinical